If you got a question, look no further.
We post the most common questions
in our FAQ section.
Please fill in the form below to receive a Free Sample of the Report.
Almirall SA (ALM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.The profile contains critical company information including:- Business description – A detailed description of the company’s operations and business divisions.- Corporate strategy – Analyst’s summarization of the company’s business strategy.- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.- Company history – Progression of key events associated with the company.- Major products and services – A list of major products, services and brands of the company.- Key competitors – A list of key competitors to the company.- Key employees – A list of the key executives of the company.- Executive biographies – A brief summary of the executives’ employment history.- Key operational heads – A list of personnel heading key departments/functions.- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.- Key manufacturing facilities – A list of key manufacturing facilities of the company.- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.HighlightsAlmirall SA (Almirall) is a specialty pharmaceutical company which researches, develops, manufactures and commercializes proprietary medicines and licensed products. The company’s key area of focus is dermatology covering psoriasis, eczema, acne and other skin infections. It also develops products in the autoimmune diseases including rheumatoid arthritis and multiple sclerosis; and gastrointestinal diseases including irritable bowel syndrome with constipation. Some of its major products include Actikerall, Balneum; Solaraze; Decoderm and Sativex among others. The company also works together with small and medium sized companies for the development of drugs and their marketing. It operates through affiliates in Europe and Central America and has R&D centers in Spain and Germany. Almirall is headquartered in Barcelona, Spain.Almirall SA Key Recent DevelopmentsDec 12,2016: Almirall and Nuevolution enter into global strategic collaborationNov 07,2016: Almirall 9M Results 2016: Strong Derma performance in EU and solid progress in USOct 18,2016: Almirall announces a restructuring plan in SpainJul 26,2016: Almirall H1 results 2016: Growth in Total Revenues and Net Sales driven by DermatologyMay 09,2016: Almirall's Q1 results 2016: on track to achieve yearly guidanceKey benefits of buying this profile include:You get detailed information about the company and its operations to identify potential customers and suppliers.- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.Gain key insights into the company for academic or business research.- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.Note: Some sections may be missing if data is unavailable for the company
Table of ContentsTable of Contents 3List of Tables 4List of Figures 4Section 1 - About the Company 5Almirall SA - Key Facts 5Almirall SA - Key Employees 6Almirall SA - Key Employee Biographies 7Almirall SA - Major Products and Services 8Almirall SA - History 9Almirall SA - Company Statement 13Almirall SA - Locations And Subsidiaries 14Head Office 14Other Locations & Subsidiaries 14Section 2 – Company Analysis 16Almirall SA - Business Description 16Almirall SA - Corporate Strategy 17Almirall SA - SWOT Analysis 18SWOT Analysis - Overview 18Almirall SA - Strengths 18Almirall SA - Weaknesses 19Almirall SA - Opportunities 20Almirall SA - Threats 21Almirall SA - Key Competitors 22Section 3 – Company Financial Ratios 23Financial Ratios - Capital Market Ratios 23Financial Ratios - Annual Ratios 24Performance Chart 27Financial Performance 27Financial Ratios - Interim Ratios 28Financial Ratios - Ratio Charts 29Section 4 – Company’s Lifesciences Financial Deals and Alliances 30Almirall SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 30Almirall SA, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 31Almirall SA, Recent Deals Summary 32Section 5 – Company’s Recent Developments 33Dec 12, 2016: Almirall and Nuevolution enter into global strategic collaboration 33Nov 07, 2016: Almirall 9M Results 2016: Strong Derma performance in EU and solid progress in US 34Jul 26, 2016: Almirall H1 results 2016: Growth in Total Revenues and Net Sales driven by Dermatology 36May 09, 2016: Almirall's Q1 results 2016: on track to achieve yearly guidance 38Feb 24, 2016: Almirall reduces its accident rate by 69% in Spain in 2015 40Feb 22, 2016: Almirall Full-Year 2015 results: Normalized Net Income growth of 90% 41Feb 22, 2016: Almirall Full-Year 2015 results: Normalized Net Income growth of 90% 43Section 6 – Appendix 45Methodology 45Ratio Definitions 45About GlobalData 49Contact Us 49Disclaimer 49List of TablesAlmirall SA, Key Facts 5Almirall SA, Key Employees 6Almirall SA, Key Employee Biographies 7Almirall SA, Major Products and Services 8Almirall SA, History 9Almirall SA, Subsidiaries 14Almirall SA, Key Competitors 22Almirall SA, Ratios based on current share price 23Almirall SA, Annual Ratios 24Almirall SA, Annual Ratios (Cont...1) 25Almirall SA, Annual Ratios (Cont...2) 26Almirall SA, Interim Ratios 28Almirall SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 30Almirall SA, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 31Almirall SA, Recent Deals Summary 32Currency Codes 45Capital Market Ratios 45Equity Ratios 46Profitability Ratios 46Cost Ratios 47Liquidity Ratios 47Leverage Ratios 48Efficiency Ratios 48List of FiguresAlmirall SA, Performance Chart (2012 - 2016) 27Almirall SA, Ratio Charts 29Almirall SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 30Almirall SA, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 31